These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2956861)
1. Pharmacology of enoximone. Dage RC; Kariya T; Hsieh CP; Roebel LE; Cheng HC; Schnettler RA; Grisar JM Am J Cardiol; 1987 Aug; 60(5):10C-14C. PubMed ID: 2956861 [TBL] [Abstract][Full Text] [Related]
2. Effects of enoximone and isobutylmethylxanthine on contractile tension and cyclic nucleotide levels in isolated blood-perfused dog papillary muscle. Hsieh CP; Kariya T; Dage RC; Ruberg SJ J Cardiovasc Pharmacol; 1987 Feb; 9(2):230-6. PubMed ID: 2436004 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology and pharmacokinetics of enoximone. Dage RC; Okerholm RA Cardiology; 1990; 77 Suppl 3():2-13; discussion 27-33. PubMed ID: 2148277 [TBL] [Abstract][Full Text] [Related]
4. Physiologic response to the inotropic and vasodilator properties of enoximone. Janicki JS; Shroff SG; Weber KT Am J Cardiol; 1987 Aug; 60(5):15C-20C. PubMed ID: 2956862 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one). Roebel LE; Dage RC; Cheng HC; Woodward JK J Cardiovasc Pharmacol; 1982; 4(5):721-9. PubMed ID: 6182401 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological comparison of CK-2289, an inodilator agent, with milrinone and enoximone. Greenberg SS; Paul J; Luisi A Arch Int Pharmacodyn Ther; 1991; 309():103-24. PubMed ID: 1653560 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs. Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the inotropic mechanism of enoximone in guinea pig ventricular muscle. Jonas SE; Mörner N; Christley HM; Wohlfart B J Cardiovasc Pharmacol; 1990 Sep; 16(3):423-9. PubMed ID: 1700213 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one). Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949 [TBL] [Abstract][Full Text] [Related]
11. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Bonzel T; Wais U; Lehmann M; Just H Circulation; 1989 Jul; 80(1):51-64. PubMed ID: 2525432 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action. Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations. Wada Y; Taira N Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407 [TBL] [Abstract][Full Text] [Related]
14. Cardiac effects of R 79595 and its isomers (R 80122 and R 80123) in an acute heart failure model. A new class of cardiotonic agents with highly selective phosphodiesterase III inhibitory properties. Schneider J; Beck E; Heers C; Conrad C; de Chaffoy de Courcelles D; Wilffert B; Peters T Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):563-72. PubMed ID: 1470228 [TBL] [Abstract][Full Text] [Related]
15. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone. Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538 [TBL] [Abstract][Full Text] [Related]
16. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867 [TBL] [Abstract][Full Text] [Related]
17. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency]. Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyril. Ferrini R; Miragoli G; Calabi ML; Santangelo F; Godfraind T; Bravo G; Casagrande C Arzneimittelforschung; 1996 Feb; 46(2):139-45. PubMed ID: 8720302 [TBL] [Abstract][Full Text] [Related]
19. Is phosphodiesterase inhibition arrhythmogenic? Electrophysiologic effects in pithed rats and in normoxic and hypoxic rabbit atria of enoximone, a new cardiotonic agent. Vaughan Williams EM J Clin Pharmacol; 1987 Feb; 27(2):91-100. PubMed ID: 2960699 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA; Johnson DC Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]